SAG and hepatocellular carcinoma: On the premise that SAG is most highly upregulated at the early stage of HCC, it was proposed that SAG-UPS is an efficient marker for early diagnosis as well as a potential target for development of therapeutics against chronic inflammation-associated hepatoma.